FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3030428981> ?p ?o ?g. }

• W3030428981 endingPage "81" @default.
• W3030428981 startingPage "75" @default.
• W3030428981 abstract "Background: Vedolizumab is an α4β7 integrin antagonist with gut-specific effects on lymphocyte and monocyte trafficking. Although the treatment is beneficial for inflammatory bowel disease (IBD), the effects of vedolizumab on extraintestinal manifestations (EIMs) have not been well described. The gut-specific effects of the medication may have diverse outcomes on EIMs. We hypothesize that EIMs may be unmasked by systemic availability of gut-homing effector cells. Aim: The goal of this study is to describe de novo EIMs of IBD patients who were started on vedolizumab. Methods: A retrospective chart review of 71 patients from January 2011 to October 2017, including clinical and medication history and colonoscopy results, was performed. Results: EIMs occurred in 26.7% of patients who were started on vedolizumab. The most common EIMs were arthralgias, perianal fistula, and pyoderma gangrenosum. There was a trend toward a greater occurrence of EIMs in patients with Crohn's disease compared to ulcerative colitis. Conclusion: Our retrospective study suggests that inhibition of gut-specific effector cells results in activated lymphocytes and/or monocytes that cause inflammation in other tissues. More studies are needed to confirm these observations and to develop biomarkers that predict patients at risk for EIMs and perianal fistulas while on vedolizumab." @default.
• W3030428981 created "2020-06-05" @default.
• W3030428981 creator A5002407135 @default.
• W3030428981 creator A5002954470 @default.
• W3030428981 creator A5005261303 @default.
• W3030428981 creator A5012357829 @default.
• W3030428981 creator A5019378404 @default.
• W3030428981 creator A5043166207 @default.
• W3030428981 creator A5089433892 @default.
• W3030428981 date "2020-02-01" @default.
• W3030428981 modified "2023-10-03" @default.
• W3030428981 title "Vedolizumab-Induced De Novo Extraintestinal Manifestations." @default.
• W3030428981 cites W1579881416 @default.
• W3030428981 cites W2009025779 @default.
• W3030428981 cites W2019886362 @default.
• W3030428981 cites W2037271656 @default.
• W3030428981 cites W2100942700 @default.
• W3030428981 cites W2110286478 @default.
• W3030428981 cites W2121116119 @default.
• W3030428981 cites W2133607388 @default.
• W3030428981 cites W2153438195 @default.
• W3030428981 cites W2162805528 @default.
• W3030428981 cites W2177651241 @default.
• W3030428981 cites W2274605499 @default.
• W3030428981 cites W2276196324 @default.
• W3030428981 cites W2301614008 @default.
• W3030428981 cites W2372967567 @default.
• W3030428981 cites W2401938788 @default.
• W3030428981 cites W2427633307 @default.
• W3030428981 cites W2510823796 @default.
• W3030428981 cites W2513780568 @default.
• W3030428981 cites W2557558841 @default.
• W3030428981 cites W2575842686 @default.
• W3030428981 cites W2587065835 @default.
• W3030428981 cites W2641366097 @default.
• W3030428981 cites W2780677699 @default.
• W3030428981 cites W2789603175 @default.
• W3030428981 cites W2791134774 @default.
• W3030428981 cites W2797152839 @default.
• W3030428981 cites W2808336191 @default.
• W3030428981 cites W2809894743 @default.
• W3030428981 cites W2885490300 @default.
• W3030428981 cites W2887744125 @default.
• W3030428981 cites W2892816546 @default.
• W3030428981 cites W2914936826 @default.
• W3030428981 cites W1990054617 @default.
• W3030428981 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8132677" @default.
• W3030428981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34035705" @default.
• W3030428981 hasPublicationYear "2020" @default.
• W3030428981 type Work @default.
• W3030428981 sameAs 3030428981 @default.
• W3030428981 citedByCount "5" @default.
• W3030428981 countsByYear W30304289812021 @default.
• W3030428981 countsByYear W30304289812022 @default.
• W3030428981 crossrefType "journal-article" @default.
• W3030428981 hasAuthorship W3030428981A5002407135 @default.
• W3030428981 hasAuthorship W3030428981A5002954470 @default.
• W3030428981 hasAuthorship W3030428981A5005261303 @default.
• W3030428981 hasAuthorship W3030428981A5012357829 @default.
• W3030428981 hasAuthorship W3030428981A5019378404 @default.
• W3030428981 hasAuthorship W3030428981A5043166207 @default.
• W3030428981 hasAuthorship W3030428981A5089433892 @default.
• W3030428981 hasConcept C126322002 @default.
• W3030428981 hasConcept C167135981 @default.
• W3030428981 hasConcept C203014093 @default.
• W3030428981 hasConcept C2776207728 @default.
• W3030428981 hasConcept C2778260677 @default.
• W3030428981 hasConcept C2779134260 @default.
• W3030428981 hasConcept C2779280984 @default.
• W3030428981 hasConcept C2780479503 @default.
• W3030428981 hasConcept C2780520777 @default.
• W3030428981 hasConcept C71924100 @default.
• W3030428981 hasConcept C90924648 @default.
• W3030428981 hasConceptScore W3030428981C126322002 @default.
• W3030428981 hasConceptScore W3030428981C167135981 @default.
• W3030428981 hasConceptScore W3030428981C203014093 @default.
• W3030428981 hasConceptScore W3030428981C2776207728 @default.
• W3030428981 hasConceptScore W3030428981C2778260677 @default.
• W3030428981 hasConceptScore W3030428981C2779134260 @default.
• W3030428981 hasConceptScore W3030428981C2779280984 @default.
• W3030428981 hasConceptScore W3030428981C2780479503 @default.
• W3030428981 hasConceptScore W3030428981C2780520777 @default.
• W3030428981 hasConceptScore W3030428981C71924100 @default.
• W3030428981 hasConceptScore W3030428981C90924648 @default.
• W3030428981 hasIssue "2" @default.
• W3030428981 hasLocation W30304289811 @default.
• W3030428981 hasOpenAccess W3030428981 @default.
• W3030428981 hasPrimaryLocation W30304289811 @default.
• W3030428981 hasRelatedWork W1642017120 @default.
• W3030428981 hasRelatedWork W1966802687 @default.
• W3030428981 hasRelatedWork W2019593469 @default.
• W3030428981 hasRelatedWork W2020840279 @default.
• W3030428981 hasRelatedWork W2024261774 @default.
• W3030428981 hasRelatedWork W2087865175 @default.
• W3030428981 hasRelatedWork W2468868935 @default.
• W3030428981 hasRelatedWork W2550585723 @default.
• W3030428981 hasRelatedWork W2640926383 @default.
• W3030428981 hasRelatedWork W2789287970 @default.

• next